FDA.reportPublic FDA data

10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]

RxCUI
2102440
RxNorm name
10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
Display name
10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
Full name
10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125587PanzygaImmune Globulin Intravenous (Human)-ifas351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68a5ee5f-0352-b3ae-3321-c0a22947a31dpanzyga 10 % in 10 ML Injection [PSN] · 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 10 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 10 ML Injection [SY]411These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
e2cc5ddf-119e-ade3-79c2-c712cfbee099panzyga 10 % in 10 ML Injection [PSN] · 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 10 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 10 ML Injection [SY]410These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0panzyga 10 % in 10 ML Injection [PSN] · 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 10 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 10 ML Injection [SY]42These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508